Browse: Departments   Dates   Agencies  

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Food and Drug Administration

NOTICE: NOTICES

ACTION: Meetings:

DOCUMENT ACTION: Notice.

SUBJECT CATEGORY: Advisory Committees; Tentative Schedule of Meetings for 2004

DOCUMENT SUMMARY: The Food and Drug Administration (FDA) is announcing a tentative schedule of forthcoming meetings of its public advisory committees for 2004. During 1991, at the request of the Commissioner of Food and Drugs (the Commissioner), the Institute of Medicine (IOM) conducted a study of the use of FDA's advisory committees. In its final report, one of IOM's recommendations was for the agency to publish an annual tentative schedule of its meetings in the Federal Register. This publication implements IOM's recommendation.

SUMMARY: Advisory committees; 2004 schedule,

SUPPLEMENTAL INFORMATION

IOM, at the request of the Commissioner, undertook a study of the use of FDA's advisory committees. In its final report in 1992, one of IOM's recommendations was for FDA to adopt a policy of publishing an advance yearly schedule of its upcoming public advisory committee meetings in the Federal Register. FDA has implemented this recommendation. The annual publication of tentatively scheduled advisory committee meetings will provide both advisory committee members and the public with the opportunity, in advance, to schedule attendance at FDA's upcoming advisory committee meetings. Because the schedule is tentative, amendments to this notice will not be published in the Federal Register. However, changes to the schedule will be posted on FDA's advisory committees' Internet site located at http://www.fda.gov/oc/advisory/default.htm. FDA will continue to publish a Federal Register notice 15 days in advance of each upcoming advisory committee meeting, to announce the meeting (21 CFR 14.20).

The following list announces FDA's tentatively scheduled advisory committee meetings for 2004. You may also obtain uptodate meeting information by calling the Advisory Committee Information Line, 1800 7418138 (3014430572 in the Washington, DC area).
Advisory Committee 10 Committee Name Date(s) of Digit Meetings Information Line Code OFFICE OF THE COMMISSIONER
Science Board to the Food and Drug April 22, 3014512603 Administration November 4
CENTER FOR BIOLOGICS EVALUATION AND RESEARCH
Allergenic Products Advisory April 2 3014512388 Committee
Biological Response Modifiers March 1819, 3014512389 Advisory Committee July 1516,
November 1819
Blood Products Advisory Committee March 1819, 3014519516 July 1213,
October 2122
Transmissible Spongiform February 1213, 3014512392 Encephalopathies Advisory Committee June 2930,
October 1415
[[Page 75575]]
Vaccines and Related Biological February 1819, 3014512391 Products Advisory Committee May 67,
September 22
23, November 17
18
CENTER FOR DRUG EVALUATION AND RESEARCH
Anesthetic and Life Support Drugs March 2425, 3014512529 Advisory Committee June 910,
August 1011,
November 1718
AntiInfective Drugs Advisory February 2 3014512530 Committee Joint Meeting
with Pediatric
Subcommittee
and
Psychopharmacol
ogic Drugs
Advisory
Committee,
February 34
Pediatric
Subcommittee
Antiviral Drugs Advisory Committee April 2728, 3014512531 October 2728
Arthritis Advisory Committee May 1213, July 3014512532 1415, October
2122
Cardiovascular and Drugs Health May 67, July 3014512533 Advisory Committee 16, August 56
Dermatologic and Ophthalmic Drugs February 2627 3014512534 Advisory Committee Joint Meeting
with Drug
Safety and Risk
Management
Advisory
Committee,
April 12, May
67, June 24
25, August 26
27, September 9
10
Drug Safety and Risk Management February 2627 3014512535 Advisory Committee Joint Meeting
with
Dermatologic
and Ophthalmic
Drugs Advisory
Committee,
April 2223,
June 34,
September 910,
November 45
Endocrinologic and Metabolic Drugs February 2627, 3014512536 Advisory Committee April 2223,
June 2223,
September 23
Gastrointestinal Drugs Advisory To Be Announced 3014512538 Committee
Nonprescription Drugs Advisory MarchDay To Be 3014512541 Committee Announced
JuneDay To Be
Announced
December 16
Joint Meeting
with Advisory
Committee for
Reproductive
Health Drugs
Oncologic Drugs Advisory Committee March 1617, 3014512542 June 1516
Peripheral and Central Nervous To Be Announced 3014512543 System Drugs
Pharmaceutical Science, Advisory April 1314 3014512539 Committee for
Psychopharmacologic Drugs Advisory February 2 3014512544 Committee Joint Meeting
with Anti
Infective Drugs
Advisory
Committee and
Pediatric
Subcommittee
PulmonaryAllergy Drugs Advisory June 2930, 3014512545 Committee November 45
Reproductive Health Drugs, Advisory OctoberDay To 3014512537 Committee for Be Announced,
DecemberDay
To Be Announced
CENTER FOR DEVICES AND RADIOLOGICAL HEALTH
Device Good Manufacturing Practice September 910 3014512398 Advisory Committee
[[Page 75576]]
Medical Devices Advisory Committee (Comprised of 18 Panels) Anesthesiology and Respiratory March 2526, 3014512624 Therapy Devices Panel June 1718,
September 910,
November 1516
Circulatory Systems Panel March 1718, May 3014512625 1920, July 21
22, September
2223, November
1718
Clinical Chemistry and Clinical March 3031, 3014512514 Toxicology Devices Panel June 2425,
September 16
17, December 6
7
Dental Products Panel April 1415 3014512518 Ear, Nose, and Throat Devices April 2122, 3014512522 Panel June 1516,
August 3031,
October 67,
December 12
GastroenterologyUrology Devices April 30, July 3014512523 Panel 16, October 22
General and Plastic Surgery March 1112, May 3014512519 Devices Panel 2627, August 9
10, October 18
19
General Hospital and Personal Use April 67, July 3014512520 Devices Panel 1213, October
1819
Hematology and Pathology Devices April 23, 3014512515 Panel October 22
Immunology Devices Panel February 26, 3014512516 April 23,
October 22
Medical Devices Dispute Resolution To Be Announced 3014510232 Panel as Needed
Microbiology Devices Panel April 89, July 3014512517 2930, November
910
Molecular and Clinical Genetics April 2829, 3014510231 Panel July 1920,
October 2021
Neurological Devices Panel February 23, 3014512513 April 12,
August 56,
October 2829
Obstetrics and Gynecology Devices April 2627, 3014512524 Panel July 2627,
October 2526
Ophthalmic Devices Panel February 56, 3014512396 March 45, May
1314, July 8
9, September 22
23, November 4
5
Orthopaedic and Rehabilitation March 2223, 3014512521 Devices Panel June 34,
August 1213,
December 23
Radiological Devices Panel February 3, May 3014512526 18, August 10,
November 16
National Mammography Quality April 5 3014512397 Assurance Advisory Committee
Technical Electronic Product None 3014512399 Radiation Safety Standards
Committee
CENTER FOR FOOD SAFETY AND APPLIED NUTRITION
Food Advisory CommitteeFull August 1617 3014510564 Committee and Subcommittee
Additives and Ingredients May 2627 3014510564 Subcommittee
Biotechnology Subcommittee July 2122 3014510564 Contaminants and Natural Toxicants November 1617 3014510564 Subcommittee
[[Page 75577]]
Dietary Supplements Subcommittee September 1415 3014510564 Infant Formula June 2223 3014510564 Nutrition Subcommittee March 3031 3014510564 CENTER FOR VETERINARY MEDICINE
Veterinary Medicine Advisory September 2324 3014512548 Committee
NATIONAL CENTER FOR TOXICOLOGICAL RESEARCH
Science Advisory Board to National August 11 3014512559 Center for Toxicological Research
Advisory Committee on Special January 21, 3014512560 Studies Relating to the Possible April 12,
LongTerm Health Effects of August 3,
Herbicides and Contaminants October 26

Dated: December 23, 2003.
Peter J. Pitts,
Associate Commissioner for External Relations.
[FR Doc. 0332103 Filed 123003; 8:45 am]
BILLING CODE 416001S

FOR FURTHER INFORMATION CONTACT Theresa L. Green, Advisory Committee Oversight and Management Staff (HF4), Food and Drug Administration, 5600 Fishers Lane, Rockville, MD 20857, 3018271220.